MedSci专访周建主任:研究与科研成果转化的重要意义

2015-10-14 MedSci MedSci原创

由长海医院血管外科主办的2015年国际腔内血管学大会于10月8日至11日在上海隆重召开。 本次大会力求搭建国际平台,展示前沿技术,激发热点讨论,演示精彩手术,并得到了来自世界各地的血管外科学及相关学科专家、学者的大力支持。 MedSci有幸采访了上海长海医院血管外科周建主任。 MedSci:周主任,您好,感谢您接受MedSci的采访,今年的大会我们在中国医师协会腔内血管学专业委员会领导下的

由长海医院血管外科主办的2015年国际腔内血管学大会于10月8日至11日在上海隆重召开。 本次大会力求搭建国际平台,展示前沿技术,激发热点讨论,演示精彩手术,并得到了来自世界各地的血管外科学及相关学科专家、学者的大力支持。

MedSci有幸采访了上海长海医院血管外科周建主任。

MedSci:周主任,您好,感谢您接受MedSci的采访,今年的大会我们在中国医师协会腔内血管学专业委员会领导下的成立了21个专委会,您作为专科委员会的研究与转化主任委员,简单跟我们分享一下您个人的感想?

周主任:腔内血管学的指向是血管疾病。 随着人口老龄化和我国人民生活水平的提高,血管疾病的发生对人民群众的危害是越来越大, 那么在血管疾病治疗诊断的临床工作者带来了新的挑战。对于传统医学来说又有着新的特点,这类疾病的发生面很广,预后非常差,且极易发生中风,偏瘫以及一些严重的不良事件,在这种情况下,也使得我们这样的医学工作者, 更需要把我们的治疗技术及相应的研究得到转化,进一步的推进, 也正是在这个背景下,在中国医师协会腔内血管学专业委员会的支持和促进下集合我们国内腔内血管学研究和转化的主干力量成立了研究与转化的专家委员会,通过这个专家委员会的成立,我们希望能够聚合多学科的力量,以及相应的研究的力量,包括我们在临床医学方面,包括血管咳, 心胸外科, 影像医学, 介入医学, 超声影像等等,将资源能够充分的整合, 实现真正的研究转化,推进我们的研究。也希望在这一方面可以做更多的事情。

MedSci:那么我们委员会下一步的工作是否也已经落实了呢?

周主任:事实上,在委员会成立之初,我们就对针对我们国家目前血管疾病发生特点,进行了流行病学的调查以及相应的数据分析。 我们发现,实际上在我们国家的这种疾病的发生的类型和趋势,有它特定的特点,在过去我们更多的是套用国外的治疗模式,我想在接下来一个阶段,我们希望能挖掘更多国内相关疾病的预防和诊断,为广大医生提供更好的科学依据。

MedSci:你刚刚谈到成果转化,那么临床工作者与研究工作者之间怎么才能更好的链接?

周主任:临床医生在治疗疾病中的着眼点在疾病本身,而研究工作者往往是对于疾病的发生或是相应的不良预后的指标判断等等,换句话说就是在我们的临床工作者和我们的研究工作中者中间, 其实在他们之间是有一些空间需要去链接,我们应该充分利用媒体,新信息手段等去促进这种关系。

对于我个人来说委员会的成立是一个很好的锲机和提升空间。对于我们从事血管疾病以及腔内血管疾病治疗的工作者而言, 往往感觉自己在单打独斗, 缺少一个团队缺少一个, 在更广和更高层次上能够聚合资源的一个空间和渠道, 那么通过专家委员会的成立不仅有我们的临床的一线的工作者,我们还有从事相应的基础医学的及材料学研究的科研工作者, 还有将这些器具真正到用用于产品化推道产品化,真正能够有共同着眼点于血管疾病和腔内血管疾病的诊治。这也是研究与转化的专家委员会的成立指向之所在。

最后,希望不管是临床工作者还是研究工作者都志同道合者都能聚合在一起,提高血管疾病的治疗水平,推动整个血管疾病诊治的发展。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (9)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2105009, encodeId=88612105009dd, content=..........学术混子, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=61365133199, createdName=470135624_53486155, createdTime=Thu Dec 08 23:24:01 CST 2022, time=2022-12-08, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1689878, encodeId=708616898e86c, content=<a href='/topic/show?id=a6fd540305d' target=_blank style='color:#2F92EE;'>#成果转化#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54030, encryptionId=a6fd540305d, topicName=成果转化)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4b5828899049, createdName=ms6323715314570549, createdTime=Sat Jul 30 02:15:00 CST 2016, time=2016-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1803192, encodeId=0a311803192e3, content=<a href='/topic/show?id=9d7ee5029bd' target=_blank style='color:#2F92EE;'>#科研成果转化#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=75029, encryptionId=9d7ee5029bd, topicName=科研成果转化)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIibticIBly5jCSic5ZElW4He3rO4DMpUHUFaFX57OicNMnzckWaicBNeStwugWHFCuOdicoakApM4HGmtw/132, createdBy=f8672500006, createdName=ms6390871039024434, createdTime=Fri Jan 01 08:15:00 CST 2016, time=2016-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1703190, encodeId=d1a71e0319021, content=<a href='/topic/show?id=dba720e31b7' target=_blank style='color:#2F92EE;'>#专访#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20731, encryptionId=dba720e31b7, topicName=专访)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=070a30497323, createdName=flyingeagle87, createdTime=Tue Dec 08 20:15:00 CST 2015, time=2015-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1814812, encodeId=b0d3181481273, content=<a href='/topic/show?id=001d9606556' target=_blank style='color:#2F92EE;'>#重要意义#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96065, encryptionId=001d9606556, topicName=重要意义)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=仁心济世, createdTime=Fri Jan 01 07:15:00 CST 2016, time=2016-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=40289, encodeId=5bc7402897f, content=好的平台好的发展, beContent=null, objectType=article, channel=null, level=null, likeNumber=155, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=df9e1651052, createdName=三三五五, createdTime=Thu Oct 22 20:27:00 CST 2015, time=2015-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1606660, encodeId=a48d160666038, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Fri Oct 16 07:15:00 CST 2015, time=2015-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=38894, encodeId=0ca63889494, content=蛮好, beContent=null, objectType=article, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=435a1619509, createdName=szzyy4818, createdTime=Thu Oct 15 07:42:00 CST 2015, time=2015-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=38892, encodeId=e4943889206, content=协会即平台, beContent=null, objectType=article, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201205/e96b3d935daf4e258fba69d60175f0ab/b6d3ee4a3a414b8eafaf7c5e905937a2.jpg, createdBy=ad4b83208, createdName=vpssa, createdTime=Thu Oct 15 07:38:00 CST 2015, time=2015-10-15, status=1, ipAttribution=)]
    2022-12-08 470135624_53486155 来自上海

    ..........学术混子

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2105009, encodeId=88612105009dd, content=..........学术混子, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=61365133199, createdName=470135624_53486155, createdTime=Thu Dec 08 23:24:01 CST 2022, time=2022-12-08, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1689878, encodeId=708616898e86c, content=<a href='/topic/show?id=a6fd540305d' target=_blank style='color:#2F92EE;'>#成果转化#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54030, encryptionId=a6fd540305d, topicName=成果转化)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4b5828899049, createdName=ms6323715314570549, createdTime=Sat Jul 30 02:15:00 CST 2016, time=2016-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1803192, encodeId=0a311803192e3, content=<a href='/topic/show?id=9d7ee5029bd' target=_blank style='color:#2F92EE;'>#科研成果转化#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=75029, encryptionId=9d7ee5029bd, topicName=科研成果转化)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIibticIBly5jCSic5ZElW4He3rO4DMpUHUFaFX57OicNMnzckWaicBNeStwugWHFCuOdicoakApM4HGmtw/132, createdBy=f8672500006, createdName=ms6390871039024434, createdTime=Fri Jan 01 08:15:00 CST 2016, time=2016-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1703190, encodeId=d1a71e0319021, content=<a href='/topic/show?id=dba720e31b7' target=_blank style='color:#2F92EE;'>#专访#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20731, encryptionId=dba720e31b7, topicName=专访)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=070a30497323, createdName=flyingeagle87, createdTime=Tue Dec 08 20:15:00 CST 2015, time=2015-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1814812, encodeId=b0d3181481273, content=<a href='/topic/show?id=001d9606556' target=_blank style='color:#2F92EE;'>#重要意义#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96065, encryptionId=001d9606556, topicName=重要意义)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=仁心济世, createdTime=Fri Jan 01 07:15:00 CST 2016, time=2016-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=40289, encodeId=5bc7402897f, content=好的平台好的发展, beContent=null, objectType=article, channel=null, level=null, likeNumber=155, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=df9e1651052, createdName=三三五五, createdTime=Thu Oct 22 20:27:00 CST 2015, time=2015-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1606660, encodeId=a48d160666038, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Fri Oct 16 07:15:00 CST 2015, time=2015-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=38894, encodeId=0ca63889494, content=蛮好, beContent=null, objectType=article, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=435a1619509, createdName=szzyy4818, createdTime=Thu Oct 15 07:42:00 CST 2015, time=2015-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=38892, encodeId=e4943889206, content=协会即平台, beContent=null, objectType=article, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201205/e96b3d935daf4e258fba69d60175f0ab/b6d3ee4a3a414b8eafaf7c5e905937a2.jpg, createdBy=ad4b83208, createdName=vpssa, createdTime=Thu Oct 15 07:38:00 CST 2015, time=2015-10-15, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=2105009, encodeId=88612105009dd, content=..........学术混子, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=61365133199, createdName=470135624_53486155, createdTime=Thu Dec 08 23:24:01 CST 2022, time=2022-12-08, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1689878, encodeId=708616898e86c, content=<a href='/topic/show?id=a6fd540305d' target=_blank style='color:#2F92EE;'>#成果转化#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54030, encryptionId=a6fd540305d, topicName=成果转化)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4b5828899049, createdName=ms6323715314570549, createdTime=Sat Jul 30 02:15:00 CST 2016, time=2016-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1803192, encodeId=0a311803192e3, content=<a href='/topic/show?id=9d7ee5029bd' target=_blank style='color:#2F92EE;'>#科研成果转化#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=75029, encryptionId=9d7ee5029bd, topicName=科研成果转化)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIibticIBly5jCSic5ZElW4He3rO4DMpUHUFaFX57OicNMnzckWaicBNeStwugWHFCuOdicoakApM4HGmtw/132, createdBy=f8672500006, createdName=ms6390871039024434, createdTime=Fri Jan 01 08:15:00 CST 2016, time=2016-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1703190, encodeId=d1a71e0319021, content=<a href='/topic/show?id=dba720e31b7' target=_blank style='color:#2F92EE;'>#专访#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20731, encryptionId=dba720e31b7, topicName=专访)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=070a30497323, createdName=flyingeagle87, createdTime=Tue Dec 08 20:15:00 CST 2015, time=2015-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1814812, encodeId=b0d3181481273, content=<a href='/topic/show?id=001d9606556' target=_blank style='color:#2F92EE;'>#重要意义#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96065, encryptionId=001d9606556, topicName=重要意义)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=仁心济世, createdTime=Fri Jan 01 07:15:00 CST 2016, time=2016-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=40289, encodeId=5bc7402897f, content=好的平台好的发展, beContent=null, objectType=article, channel=null, level=null, likeNumber=155, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=df9e1651052, createdName=三三五五, createdTime=Thu Oct 22 20:27:00 CST 2015, time=2015-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1606660, encodeId=a48d160666038, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Fri Oct 16 07:15:00 CST 2015, time=2015-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=38894, encodeId=0ca63889494, content=蛮好, beContent=null, objectType=article, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=435a1619509, createdName=szzyy4818, createdTime=Thu Oct 15 07:42:00 CST 2015, time=2015-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=38892, encodeId=e4943889206, content=协会即平台, beContent=null, objectType=article, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201205/e96b3d935daf4e258fba69d60175f0ab/b6d3ee4a3a414b8eafaf7c5e905937a2.jpg, createdBy=ad4b83208, createdName=vpssa, createdTime=Thu Oct 15 07:38:00 CST 2015, time=2015-10-15, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=2105009, encodeId=88612105009dd, content=..........学术混子, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=61365133199, createdName=470135624_53486155, createdTime=Thu Dec 08 23:24:01 CST 2022, time=2022-12-08, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1689878, encodeId=708616898e86c, content=<a href='/topic/show?id=a6fd540305d' target=_blank style='color:#2F92EE;'>#成果转化#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54030, encryptionId=a6fd540305d, topicName=成果转化)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4b5828899049, createdName=ms6323715314570549, createdTime=Sat Jul 30 02:15:00 CST 2016, time=2016-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1803192, encodeId=0a311803192e3, content=<a href='/topic/show?id=9d7ee5029bd' target=_blank style='color:#2F92EE;'>#科研成果转化#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=75029, encryptionId=9d7ee5029bd, topicName=科研成果转化)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIibticIBly5jCSic5ZElW4He3rO4DMpUHUFaFX57OicNMnzckWaicBNeStwugWHFCuOdicoakApM4HGmtw/132, createdBy=f8672500006, createdName=ms6390871039024434, createdTime=Fri Jan 01 08:15:00 CST 2016, time=2016-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1703190, encodeId=d1a71e0319021, content=<a href='/topic/show?id=dba720e31b7' target=_blank style='color:#2F92EE;'>#专访#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20731, encryptionId=dba720e31b7, topicName=专访)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=070a30497323, createdName=flyingeagle87, createdTime=Tue Dec 08 20:15:00 CST 2015, time=2015-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1814812, encodeId=b0d3181481273, content=<a href='/topic/show?id=001d9606556' target=_blank style='color:#2F92EE;'>#重要意义#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96065, encryptionId=001d9606556, topicName=重要意义)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=仁心济世, createdTime=Fri Jan 01 07:15:00 CST 2016, time=2016-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=40289, encodeId=5bc7402897f, content=好的平台好的发展, beContent=null, objectType=article, channel=null, level=null, likeNumber=155, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=df9e1651052, createdName=三三五五, createdTime=Thu Oct 22 20:27:00 CST 2015, time=2015-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1606660, encodeId=a48d160666038, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Fri Oct 16 07:15:00 CST 2015, time=2015-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=38894, encodeId=0ca63889494, content=蛮好, beContent=null, objectType=article, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=435a1619509, createdName=szzyy4818, createdTime=Thu Oct 15 07:42:00 CST 2015, time=2015-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=38892, encodeId=e4943889206, content=协会即平台, beContent=null, objectType=article, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201205/e96b3d935daf4e258fba69d60175f0ab/b6d3ee4a3a414b8eafaf7c5e905937a2.jpg, createdBy=ad4b83208, createdName=vpssa, createdTime=Thu Oct 15 07:38:00 CST 2015, time=2015-10-15, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=2105009, encodeId=88612105009dd, content=..........学术混子, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=61365133199, createdName=470135624_53486155, createdTime=Thu Dec 08 23:24:01 CST 2022, time=2022-12-08, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1689878, encodeId=708616898e86c, content=<a href='/topic/show?id=a6fd540305d' target=_blank style='color:#2F92EE;'>#成果转化#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54030, encryptionId=a6fd540305d, topicName=成果转化)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4b5828899049, createdName=ms6323715314570549, createdTime=Sat Jul 30 02:15:00 CST 2016, time=2016-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1803192, encodeId=0a311803192e3, content=<a href='/topic/show?id=9d7ee5029bd' target=_blank style='color:#2F92EE;'>#科研成果转化#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=75029, encryptionId=9d7ee5029bd, topicName=科研成果转化)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIibticIBly5jCSic5ZElW4He3rO4DMpUHUFaFX57OicNMnzckWaicBNeStwugWHFCuOdicoakApM4HGmtw/132, createdBy=f8672500006, createdName=ms6390871039024434, createdTime=Fri Jan 01 08:15:00 CST 2016, time=2016-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1703190, encodeId=d1a71e0319021, content=<a href='/topic/show?id=dba720e31b7' target=_blank style='color:#2F92EE;'>#专访#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20731, encryptionId=dba720e31b7, topicName=专访)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=070a30497323, createdName=flyingeagle87, createdTime=Tue Dec 08 20:15:00 CST 2015, time=2015-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1814812, encodeId=b0d3181481273, content=<a href='/topic/show?id=001d9606556' target=_blank style='color:#2F92EE;'>#重要意义#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96065, encryptionId=001d9606556, topicName=重要意义)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=仁心济世, createdTime=Fri Jan 01 07:15:00 CST 2016, time=2016-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=40289, encodeId=5bc7402897f, content=好的平台好的发展, beContent=null, objectType=article, channel=null, level=null, likeNumber=155, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=df9e1651052, createdName=三三五五, createdTime=Thu Oct 22 20:27:00 CST 2015, time=2015-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1606660, encodeId=a48d160666038, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Fri Oct 16 07:15:00 CST 2015, time=2015-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=38894, encodeId=0ca63889494, content=蛮好, beContent=null, objectType=article, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=435a1619509, createdName=szzyy4818, createdTime=Thu Oct 15 07:42:00 CST 2015, time=2015-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=38892, encodeId=e4943889206, content=协会即平台, beContent=null, objectType=article, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201205/e96b3d935daf4e258fba69d60175f0ab/b6d3ee4a3a414b8eafaf7c5e905937a2.jpg, createdBy=ad4b83208, createdName=vpssa, createdTime=Thu Oct 15 07:38:00 CST 2015, time=2015-10-15, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=2105009, encodeId=88612105009dd, content=..........学术混子, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=61365133199, createdName=470135624_53486155, createdTime=Thu Dec 08 23:24:01 CST 2022, time=2022-12-08, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1689878, encodeId=708616898e86c, content=<a href='/topic/show?id=a6fd540305d' target=_blank style='color:#2F92EE;'>#成果转化#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54030, encryptionId=a6fd540305d, topicName=成果转化)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4b5828899049, createdName=ms6323715314570549, createdTime=Sat Jul 30 02:15:00 CST 2016, time=2016-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1803192, encodeId=0a311803192e3, content=<a href='/topic/show?id=9d7ee5029bd' target=_blank style='color:#2F92EE;'>#科研成果转化#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=75029, encryptionId=9d7ee5029bd, topicName=科研成果转化)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIibticIBly5jCSic5ZElW4He3rO4DMpUHUFaFX57OicNMnzckWaicBNeStwugWHFCuOdicoakApM4HGmtw/132, createdBy=f8672500006, createdName=ms6390871039024434, createdTime=Fri Jan 01 08:15:00 CST 2016, time=2016-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1703190, encodeId=d1a71e0319021, content=<a href='/topic/show?id=dba720e31b7' target=_blank style='color:#2F92EE;'>#专访#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20731, encryptionId=dba720e31b7, topicName=专访)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=070a30497323, createdName=flyingeagle87, createdTime=Tue Dec 08 20:15:00 CST 2015, time=2015-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1814812, encodeId=b0d3181481273, content=<a href='/topic/show?id=001d9606556' target=_blank style='color:#2F92EE;'>#重要意义#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96065, encryptionId=001d9606556, topicName=重要意义)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=仁心济世, createdTime=Fri Jan 01 07:15:00 CST 2016, time=2016-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=40289, encodeId=5bc7402897f, content=好的平台好的发展, beContent=null, objectType=article, channel=null, level=null, likeNumber=155, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=df9e1651052, createdName=三三五五, createdTime=Thu Oct 22 20:27:00 CST 2015, time=2015-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1606660, encodeId=a48d160666038, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Fri Oct 16 07:15:00 CST 2015, time=2015-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=38894, encodeId=0ca63889494, content=蛮好, beContent=null, objectType=article, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=435a1619509, createdName=szzyy4818, createdTime=Thu Oct 15 07:42:00 CST 2015, time=2015-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=38892, encodeId=e4943889206, content=协会即平台, beContent=null, objectType=article, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201205/e96b3d935daf4e258fba69d60175f0ab/b6d3ee4a3a414b8eafaf7c5e905937a2.jpg, createdBy=ad4b83208, createdName=vpssa, createdTime=Thu Oct 15 07:38:00 CST 2015, time=2015-10-15, status=1, ipAttribution=)]
    2015-10-22 三三五五

    好的平台好的发展

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=2105009, encodeId=88612105009dd, content=..........学术混子, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=61365133199, createdName=470135624_53486155, createdTime=Thu Dec 08 23:24:01 CST 2022, time=2022-12-08, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1689878, encodeId=708616898e86c, content=<a href='/topic/show?id=a6fd540305d' target=_blank style='color:#2F92EE;'>#成果转化#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54030, encryptionId=a6fd540305d, topicName=成果转化)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4b5828899049, createdName=ms6323715314570549, createdTime=Sat Jul 30 02:15:00 CST 2016, time=2016-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1803192, encodeId=0a311803192e3, content=<a href='/topic/show?id=9d7ee5029bd' target=_blank style='color:#2F92EE;'>#科研成果转化#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=75029, encryptionId=9d7ee5029bd, topicName=科研成果转化)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIibticIBly5jCSic5ZElW4He3rO4DMpUHUFaFX57OicNMnzckWaicBNeStwugWHFCuOdicoakApM4HGmtw/132, createdBy=f8672500006, createdName=ms6390871039024434, createdTime=Fri Jan 01 08:15:00 CST 2016, time=2016-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1703190, encodeId=d1a71e0319021, content=<a href='/topic/show?id=dba720e31b7' target=_blank style='color:#2F92EE;'>#专访#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20731, encryptionId=dba720e31b7, topicName=专访)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=070a30497323, createdName=flyingeagle87, createdTime=Tue Dec 08 20:15:00 CST 2015, time=2015-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1814812, encodeId=b0d3181481273, content=<a href='/topic/show?id=001d9606556' target=_blank style='color:#2F92EE;'>#重要意义#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96065, encryptionId=001d9606556, topicName=重要意义)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=仁心济世, createdTime=Fri Jan 01 07:15:00 CST 2016, time=2016-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=40289, encodeId=5bc7402897f, content=好的平台好的发展, beContent=null, objectType=article, channel=null, level=null, likeNumber=155, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=df9e1651052, createdName=三三五五, createdTime=Thu Oct 22 20:27:00 CST 2015, time=2015-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1606660, encodeId=a48d160666038, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Fri Oct 16 07:15:00 CST 2015, time=2015-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=38894, encodeId=0ca63889494, content=蛮好, beContent=null, objectType=article, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=435a1619509, createdName=szzyy4818, createdTime=Thu Oct 15 07:42:00 CST 2015, time=2015-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=38892, encodeId=e4943889206, content=协会即平台, beContent=null, objectType=article, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201205/e96b3d935daf4e258fba69d60175f0ab/b6d3ee4a3a414b8eafaf7c5e905937a2.jpg, createdBy=ad4b83208, createdName=vpssa, createdTime=Thu Oct 15 07:38:00 CST 2015, time=2015-10-15, status=1, ipAttribution=)]
  8. [GetPortalCommentsPageByObjectIdResponse(id=2105009, encodeId=88612105009dd, content=..........学术混子, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=61365133199, createdName=470135624_53486155, createdTime=Thu Dec 08 23:24:01 CST 2022, time=2022-12-08, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1689878, encodeId=708616898e86c, content=<a href='/topic/show?id=a6fd540305d' target=_blank style='color:#2F92EE;'>#成果转化#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54030, encryptionId=a6fd540305d, topicName=成果转化)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4b5828899049, createdName=ms6323715314570549, createdTime=Sat Jul 30 02:15:00 CST 2016, time=2016-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1803192, encodeId=0a311803192e3, content=<a href='/topic/show?id=9d7ee5029bd' target=_blank style='color:#2F92EE;'>#科研成果转化#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=75029, encryptionId=9d7ee5029bd, topicName=科研成果转化)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIibticIBly5jCSic5ZElW4He3rO4DMpUHUFaFX57OicNMnzckWaicBNeStwugWHFCuOdicoakApM4HGmtw/132, createdBy=f8672500006, createdName=ms6390871039024434, createdTime=Fri Jan 01 08:15:00 CST 2016, time=2016-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1703190, encodeId=d1a71e0319021, content=<a href='/topic/show?id=dba720e31b7' target=_blank style='color:#2F92EE;'>#专访#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20731, encryptionId=dba720e31b7, topicName=专访)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=070a30497323, createdName=flyingeagle87, createdTime=Tue Dec 08 20:15:00 CST 2015, time=2015-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1814812, encodeId=b0d3181481273, content=<a href='/topic/show?id=001d9606556' target=_blank style='color:#2F92EE;'>#重要意义#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96065, encryptionId=001d9606556, topicName=重要意义)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=仁心济世, createdTime=Fri Jan 01 07:15:00 CST 2016, time=2016-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=40289, encodeId=5bc7402897f, content=好的平台好的发展, beContent=null, objectType=article, channel=null, level=null, likeNumber=155, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=df9e1651052, createdName=三三五五, createdTime=Thu Oct 22 20:27:00 CST 2015, time=2015-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1606660, encodeId=a48d160666038, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Fri Oct 16 07:15:00 CST 2015, time=2015-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=38894, encodeId=0ca63889494, content=蛮好, beContent=null, objectType=article, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=435a1619509, createdName=szzyy4818, createdTime=Thu Oct 15 07:42:00 CST 2015, time=2015-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=38892, encodeId=e4943889206, content=协会即平台, beContent=null, objectType=article, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201205/e96b3d935daf4e258fba69d60175f0ab/b6d3ee4a3a414b8eafaf7c5e905937a2.jpg, createdBy=ad4b83208, createdName=vpssa, createdTime=Thu Oct 15 07:38:00 CST 2015, time=2015-10-15, status=1, ipAttribution=)]
    2015-10-15 szzyy4818

    蛮好

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=2105009, encodeId=88612105009dd, content=..........学术混子, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=61365133199, createdName=470135624_53486155, createdTime=Thu Dec 08 23:24:01 CST 2022, time=2022-12-08, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1689878, encodeId=708616898e86c, content=<a href='/topic/show?id=a6fd540305d' target=_blank style='color:#2F92EE;'>#成果转化#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54030, encryptionId=a6fd540305d, topicName=成果转化)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4b5828899049, createdName=ms6323715314570549, createdTime=Sat Jul 30 02:15:00 CST 2016, time=2016-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1803192, encodeId=0a311803192e3, content=<a href='/topic/show?id=9d7ee5029bd' target=_blank style='color:#2F92EE;'>#科研成果转化#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=75029, encryptionId=9d7ee5029bd, topicName=科研成果转化)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIibticIBly5jCSic5ZElW4He3rO4DMpUHUFaFX57OicNMnzckWaicBNeStwugWHFCuOdicoakApM4HGmtw/132, createdBy=f8672500006, createdName=ms6390871039024434, createdTime=Fri Jan 01 08:15:00 CST 2016, time=2016-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1703190, encodeId=d1a71e0319021, content=<a href='/topic/show?id=dba720e31b7' target=_blank style='color:#2F92EE;'>#专访#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20731, encryptionId=dba720e31b7, topicName=专访)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=070a30497323, createdName=flyingeagle87, createdTime=Tue Dec 08 20:15:00 CST 2015, time=2015-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1814812, encodeId=b0d3181481273, content=<a href='/topic/show?id=001d9606556' target=_blank style='color:#2F92EE;'>#重要意义#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96065, encryptionId=001d9606556, topicName=重要意义)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=仁心济世, createdTime=Fri Jan 01 07:15:00 CST 2016, time=2016-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=40289, encodeId=5bc7402897f, content=好的平台好的发展, beContent=null, objectType=article, channel=null, level=null, likeNumber=155, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=df9e1651052, createdName=三三五五, createdTime=Thu Oct 22 20:27:00 CST 2015, time=2015-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1606660, encodeId=a48d160666038, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Fri Oct 16 07:15:00 CST 2015, time=2015-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=38894, encodeId=0ca63889494, content=蛮好, beContent=null, objectType=article, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=435a1619509, createdName=szzyy4818, createdTime=Thu Oct 15 07:42:00 CST 2015, time=2015-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=38892, encodeId=e4943889206, content=协会即平台, beContent=null, objectType=article, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201205/e96b3d935daf4e258fba69d60175f0ab/b6d3ee4a3a414b8eafaf7c5e905937a2.jpg, createdBy=ad4b83208, createdName=vpssa, createdTime=Thu Oct 15 07:38:00 CST 2015, time=2015-10-15, status=1, ipAttribution=)]
    2015-10-15 vpssa

    协会即平台

    0

相关资讯

值得关注的临床医学分科微信号!

medsci微信 神经科 研究 心血管 细胞 生物在线

癌症研究大阅兵

不同年代有不同的年代病。东汉末年中国流行伤寒,才会有伤寒杂病论。17世纪的欧洲流行天花,才会发展出种痘理论。拜人口老龄化、超重、缺乏运动和晚婚所赐,我们所处的时代,是癌症的时代。截止到2015年9月1日17时00分,PubMed(美国国立医学图书馆旗下的在线文献搜索引擎)中输入“cancer”,能搜到3,168,607篇文献,比心脏病、糖尿病、艾滋病等研究文献的总量还多。如果每篇文献有10页的

看完这些科学试验,你谈论中医的段位立刻就不一样了

前不久,在一饭局中跟一群朋友聊天,偶然聊到中医。我发现质疑中医的人,基本都是认为中医不科学。 刚好前几天看到美国加州大学艾尔文分校医学院(全美top50医学院)的一篇研究,他们发现利用针灸治疗高血压可以促进高血压病人的血压下降。这一发现激发了我对中医现代化的好奇心。 中医科学吗?科学是如何检验中医的?中医能经受科学的考验吗?这三个问题久久徘徊在我的脑海。 于是带着这些问题,我查阅了相关的

大数据研究常用软件工具与应用场景

如今,大数据日益成为研究行业的重要研究目标。面对其高数据量、多维度与异构化的特点,以及分析方法思路的扩展,传统统计工具已经难以应对。工欲善其事,必先利其器。众多新的软件分析工具作为深入大数据洞察研究的重要助力, 也成为数据科学家所必须掌握的知识技能。然而,现实情况的复杂性决定了并不存在解决一切问题的终极工具。实际研究过程中,需要根据实际情况灵活选择最合适的工具(甚至多种工具组合使用),才能更好

Sweave:打造一个可重复的统计研究流程

我们都痛恨统计造假。我们都对重复性的工作感到厌倦。如果你同意这两句话或这两句话适用于你的现状,那么本文将介绍一套开源、免费的工具来克服这两个问题。当然,前提是你愿意改变,这里的工具可以让这两种现象没有藏身之地,但无法改变造假和重复劳动的现实。以下为吊胃口视频(墙外观众可以看Vimeo;墙内看不到视频的可以任选一个链接下载本视频的AVI文件:链接1、链接2、链接3): 1. 统计研究流

盘点:2015年糖尿病疗法研究进展

据估计,目前全球有将近4亿糖尿病患者,而其发病原因大致可分为遗传和环境两大因素。而前糖尿病患者数目更加庞大,有研究者表示,截至2035年全球将有5.92亿糖尿病患者。 糖尿病分为1型和2型糖尿病,2型糖尿病占到了糖尿病患者群体的90%以上,其又名成人发病型糖尿病,患者体内产生胰岛素的能力并非完全丧失,有的患者体内胰岛素甚至产生过多,但胰岛素的作用效果较差,因此患者体内的胰岛素是一种相对缺乏